Erlotinib and Avastin in Patients With Cancer of the Esophagus or Gastroesophageal Junction

NCT00442507 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped Slow accrual

Conditions

Esophageal Neoplasms
Esophageal Diseases

Interventions

DRUG: Erlotinib
DRUG: Avastin

Sponsor

Washington University School of Medicine